Portfolio Update

4 January 2008

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                      QUARTERLY STATEMENT OF INVESTMENTS                       

The Company announces that the ten largest investments as at close of business
on 31 December 2007 were as follows:

  * Investments valuing greater than 5% of the Company's gross assets comprise
    the following:
   
Company Name                                        Value of       % of Total  
                                                 Investment at      Portfolio  
                                                                     Assets    
                                                31 December 2007               
                                                                               
MERCK & CO.                                        16,689,354         6.39     
                                                                               
SCHERING-PLOUGH CORPORATION COM USD0.50            14,840,255         5.68     
                                                                               
NOVARTIS CHF0.50 REGD                              13,766,862         5.27     
                                                                               
GENZYME CORP GENERAL DIVISION COM USD0.01          13,181,197         5.05     

  * The ten largest investments held by the Company comprise the following:
   
Company Name                                  Value of Investment   % of Total 
                                                       at           Portfolio  
                                                                      Assets   
                                                31 December 2007               
                                                                               
MERCK & CO.                                        16,689.354          6.39    
                                                                               
SCHERING-PLOUGH CORPORATION COM USD0.50            14,840,255          5.68    
                                                                               
NOVARTIS CHF0.50 REGD                              13,766,862          5.27    
                                                                               
GENZYME CORP GENERAL DIVISION COM USD0.01          13,181,197          5.05    
                                                                               
AMGEN COM USD0.0001                                12,765,984          4.89    
                                                                               
ABBOTT LABS COM NPV USD                            12,492,937          4.79    
                                                                               
GOLDMAN SACHS M&A BASKET                           12,129,678          4.65    
                                                                               
TAKEDA PHARMACEUTICAL CO NPV                       11,487,099          4.40    
                                                                               
GEN-PROBE INC USD0.0001                            11,054,516          4.23    
                                                                               
GENENTECH INC COM STK USD0.02 NPV                  10,950,342          4.19    

                                   - ENDS -                                    

For further information please contact:

Mark Pope, Company Secretary

Frostrow Capital LLP

Telephone: [phone]